Skip to main content
ABUS
NASDAQ Life Sciences

Arbutus Swings to $59.1M Third-Quarter Profit

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$3.71
Mkt Cap
$736.953M
52W Low
$3.5
52W High
$5.45
52W Position info
6.0% above low
Off High info
32% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

ABUS is trading near its 52-week low of $3.5 (6.0% above the low) on light trading volume (0.3× avg).

Summary

Arbutus posted $59.1M of third-quarter net income, a sharp swing from the $5.1M net loss it reported for Q2 2026, with earnings of 30c per share on revenue of $299,000. The profit lands after a transformative stretch: the company bought back 46M shares at $5.00 each in its $230M Dutch auction, retiring roughly 23% of shares outstanding, and the FDA lifted the clinical hold on its AB-101 hepatitis B program in late October. With the buyback shrinking the share count and the AB-101 IND reopened, the balance sheet and pipeline both look different than they did a quarter ago. The headline gives no cash balance, so the quality of the $59.1M — one-time items versus recurring — is not yet clear.

At the time of this announcement, ABUS was trading at $3.71 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $737M. The 52-week trading range was $3.50 to $5.45. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

ABUS - Latest Insights

ABUS
Nov 10, 2026, 7:31 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.71
Real-time Price: $4.09 info
Change: +$0.380 (+10%) info
Market Cap: $626.968M info
ABUS
Oct 22, 2026, 7:31 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.25
Real-time Price: $4.09 info
Change: -$0.160 (-4%) info
Market Cap: $626.968M info
ABUS
Oct 22, 2026, 7:30 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $4.24
Real-time Price: $4.09 info
Change: -$0.1497 (-4%) info
Market Cap: $626.968M info
ABUS
Sep 30, 2026, 7:35 AM EDT
Filing Type: SC TO-I/A
Importance Score:
7
Price at Filing: $4.66
Real-time Price: $4.09 info
Change: -$0.5728 (-12%) info
Market Cap: $626.968M info
ABUS
Aug 24, 2026, 8:24 AM EDT
Filing Type: SC TO-I
Importance Score:
7
Price at Filing: $5.21
Real-time Price: $4.09 info
Change: -$1.12 (-21%) info
Market Cap: $626.968M info